Bisphosphonate Use in Patients Undergoing Dialysis

Author： Vouri Scott Martin   Blaszczyk Amie Taggart  

Publisher： American Society of Consultant Pharmacists

ISSN： 0888-5109

Source： The Consultant Pharmacist, Vol.28, Iss.11, 2013-11, pp. : 738-741

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atorvastatin effectively treats dyslipidaemia in patients undergoing peritoneal dialysis

By  

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Dementia in Patients Undergoing Long-Term Dialysis: Aetiology, Differential Diagnoses, Epidemiology and Management

By Rob P.M.  

CNS Drugs, Vol. 15, Iss. 9, 2001-01 ,pp. : 691-699

Adis International

Access to resources Recommend Favorite

Effects of silymarin on biochemical and oxidative stress markers in end‐stage renal disease patients undergoing peritoneal dialysis

By  

Hemodialysis International, Vol. 20, Iss. 4, 2016-10 ,pp. : 558-563

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bivalirudin: A Review of its Use in Patients Undergoing Percutaneous Coronary Intervention

By Moen Marit D.   Keating Gillian M.   Wellington Keri  

Drugs, Vol. 65, Iss. 13, 2005-01 ,pp. : 1869-1891

Adis International

Access to resources Recommend Favorite

ASCO guidelines take a bite out of bisphosphonate use

By  

Reactions Weekly, Vol. 1, Iss. 1160, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite